BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
BECTON DICKINSON & CO
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$190.74−1.01 (-0.53%)
Close on Oct 19, 2026
- Market cap
- $52.48B
- P/E (TTM)
- 57.6
- Dividend yield
- 2.18%
Share price
+$1.64 (+0.87%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
BECTON DICKINSON & CO grew revenue 17.4% to $23.25B over the twelve months to Jun 30, 2026. Operating income rose 13.0% to $2.48B, moving the operating margin from 11.1% to 10.7%. Free cash flow was $3.20B, up 54.2% from a year earlier.
Revenue
$23.25B
+17.4% vs. a year earlier
Operating income
$2.48B
+13.0% vs. a year earlier
Free cash flow
$3.20B
+54.2% vs. a year earlier
EPS, diluted
$3.31
-39.6% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $52.48B
- P/E ratio
- 57.6
- Price to sales
- 2.26
- Price to book
- 2.15
- Dividend yield
- 2.18%
- Free cash flow yield
- 6.10%
Fundamentals
- Revenue
- $23.25B
- Net income
- $941.00M
- EPS, diluted
- $3.31
- Free cash flow
- $3.20B
- Book value per share
- $88.73
- Diluted shares
- 275M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$23.25B+17.4% YoY
Gross profit
$10.91B+23.7% YoY
Operating income
$2.48B+13.0% YoY
Net income
$941.00M-40.6% YoY
EPS, diluted
$3.31-39.6% YoY
Free cash flow
$3.20B+54.2% YoY
Reported periodTrailing twelve months